Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 34 Pancreatic Neoplasms 14 Neuroblastoma 13 Neoplasm Metastasis 11 Stomach Neoplasms 9 Neoplasms 8 Rectal Neoplasms 5 Small Cell Lung Carcinoma 4 Esophageal Squamous Cell Carcinoma 4 Colonic Neoplasms 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Ovarian Neoplasms 3 Gastrointestinal Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Wilms Tumor 2 Sarcoma 2 Recurrence 2 Osteosarcoma 2 Ganglioneuroblastoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Adenocarcinoma Of Esophagus 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Solid Tumors 1

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ampullary Adenocarcinoma × Irinotecan × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡